Ten Innovative Medical Device Companies Secure Funding and File IPO Prospectuses

Public information shows that, as of September 29, several more Chinese medical device companies announced new financing progress in September. By reviewing these companies and their product pipelines, we discovered the following highlights: In terms of R&D areas, the research directions of these companies include: fully degradable iron-based bioabsorbable stents and valve replacement products in the cardiovascular disease field; early screening, early diagnosis, and early treatment products in the oncology field; intraocular lenses and collagen sponge biomaterials in the ophthalmology field; spinal cord stimulation systems in the pain management field; imaging systems in the sports medicine field, and so on.